HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hee Jin Lee Selected Research

Silver

12/2014HER2 heterogeneity affects trastuzumab responses and survival in patients with HER2-positive metastatic breast cancer.
6/2011Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hee Jin Lee Research Topics

Disease

71Neoplasms (Cancer)
05/2024 - 07/2007
66Breast Neoplasms (Breast Cancer)
05/2024 - 06/2011
21Triple Negative Breast Neoplasms
01/2024 - 01/2014
11Neoplasm Metastasis (Metastasis)
01/2023 - 06/2014
6Carcinoma (Carcinomatosis)
03/2024 - 02/2013
6Pathologic Complete Response
02/2024 - 06/2014
5Carcinogenesis
01/2023 - 10/2014
5Adenocarcinoma
11/2014 - 08/2011
4Residual Neoplasm
11/2020 - 05/2014
4Tertiary Lymphoid Structures
01/2019 - 08/2015
3Inflammation (Inflammations)
01/2021 - 04/2014
3Noninfiltrating Intraductal Carcinoma (DCIS)
12/2020 - 11/2013
3Testicular Neoplasms (Testicular Cancer)
01/2015 - 01/2015
2Lung Neoplasms (Lung Cancer)
02/2024 - 10/2014
2Hypoxia (Hypoxemia)
01/2023 - 10/2012
2Circulating Neoplastic Cells
03/2021 - 10/2020
2Arthritis (Polyarthritis)
01/2017 - 04/2014
2Cataract (Cataracts)
05/2016 - 04/2015
2Endometrial Neoplasms (Endometrial Cancer)
01/2015 - 11/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 01/2013
2Multiple Myeloma
07/2007 - 06/2006
1Papillomavirus Infections
04/2024
1Squamous Cell Carcinoma of Head and Neck
04/2024
1Necrosis
03/2024
1Infections
02/2024
1Chronic Disease (Chronic Diseases)
01/2024
1Cerebral Palsy (Spastic Diplegia)
02/2023
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
01/2022

Drug/Important Bio-Agent (IBA)

17Hormones (Hormone)IBA
09/2023 - 07/2008
14Biomarkers (Surrogate Marker)IBA
02/2024 - 10/2012
13Proteins (Proteins, Gene)FDA Link
02/2024 - 07/2007
13human ERBB2 proteinIBA
01/2023 - 06/2011
10Trastuzumab (Herceptin)FDA Link
01/2023 - 06/2014
9Estrogen ReceptorsIBA
01/2023 - 10/2014
7RNA (Ribonucleic Acid)IBA
02/2024 - 06/2016
7MicroRNAs (MicroRNA)IBA
01/2018 - 11/2012
6InterferonsIBA
10/2022 - 04/2016
5AntigensIBA
04/2024 - 01/2015
4Cadherins (E-Cadherin)IBA
02/2024 - 02/2013
4HLA Antigens (Human Leukocyte Antigens)IBA
10/2022 - 04/2016
4ErbB Receptors (EGF Receptor)IBA
08/2021 - 11/2012
4ParaffinIBA
12/2020 - 06/2011
4Formaldehyde (Formol)FDA Link
12/2020 - 06/2011
4Phenobarbital (Luminal)FDA Link
04/2017 - 05/2014
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2024 - 06/2015
3B7-H1 AntigenIBA
04/2024 - 11/2020
3ChemokinesIBA
02/2024 - 01/2020
3EnzymesIBA
01/2021 - 09/2013
3Lapatinib (GW572016)FDA Link
10/2020 - 10/2016
3HMGB1 Protein (HMG1)IBA
01/2019 - 12/2015
3taxaneIBA
03/2018 - 01/2015
3CytokinesIBA
05/2016 - 01/2015
2Docetaxel (Taxotere)FDA Link
09/2023 - 08/2021
2Estrogens (Estrogen)FDA Link
10/2022 - 01/2014
2Dinoprostone (PGE2)FDA Link
01/2021 - 05/2016
2Progesterone Receptors (Progesterone Receptor)IBA
11/2020 - 10/2014
2Messenger RNA (mRNA)IBA
11/2020 - 07/2016
2Immune Checkpoint InhibitorsIBA
11/2020 - 01/2020
2Interferon-gamma (Interferon, gamma)IBA
11/2020 - 01/2017
2Letrozole (Femara)FDA LinkGeneric
10/2020 - 10/2016
2Epidermal Growth Factor (EGF)IBA
10/2020 - 06/2014
2Sirtuin 1IBA
07/2019 - 01/2016
2HMGN1 Protein (HMGN1)IBA
01/2019 - 12/2015
2Protein Kinases (Protein Kinase)IBA
01/2017 - 06/2016
2Heme Oxygenase-1IBA
01/2017 - 04/2014
2High Mobility Group ProteinsIBA
09/2016 - 12/2015
2Phosphotransferases (Kinase)IBA
06/2016 - 08/2014
2HLA-A Antigens (HLA-A)IBA
05/2016 - 08/2015
2Interleukin-6 (Interleukin 6)IBA
05/2016 - 01/2015
2AntioxidantsIBA
04/2015 - 04/2014
2AnthracyclinesIBA
02/2015 - 01/2015
2SilverIBA
12/2014 - 06/2011
2VimentinIBA
08/2014 - 11/2013
2CateninsIBA
11/2013 - 02/2013
2pleiotrophin (HARP)IBA
07/2007 - 06/2006
1trastuzumab deruxtecanIBA
03/2024
1ConnectinIBA
02/2024
1Chemokine ReceptorsIBA
02/2024
1ORALIT (ORS)IBA
01/2024
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2023
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2023
1LigandsIBA
12/2022
1Epithelial Cell Adhesion MoleculeIBA
12/2022
1Interleukin-8 (Interleukin 8)IBA
12/2022
1P-SelectinIBA
12/2022
1Surface Antigens (Surface Antigen)IBA
09/2022
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2022
1Collagenases (Collagenase)FDA Link
01/2022

Therapy/Procedure

22Therapeutics
02/2024 - 02/2012
21Neoadjuvant Therapy
03/2024 - 03/2013
9Immunotherapy
02/2024 - 01/2015
6Drug Therapy (Chemotherapy)
01/2024 - 06/2014
3Cell- and Tissue-Based Therapy (Cell Therapy)
05/2024 - 04/2024
3Mastectomy (Mammectomy)
01/2022 - 09/2013
3Adjuvant Chemotherapy
10/2015 - 06/2015
1Radiotherapy
01/2024
1Extracorporeal Shockwave Therapy
02/2023